Vimarsana
Biggest News Aggregation in the World

Page 31 - Sight Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sight Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sight Sciences Today - Breaking & Trending Today

Sight Sciences Announces the Appointment of Tamara - Vimarsana News

Sight Sciences Announces the Appointment of Tamara

MENLO PARK, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative...

Who cut checks to Manchin last quarter - Vimarsana News

Who cut checks to Manchin last quarter

Joe Manchin has long been a top recipient of campaign contributions from the energy sector, and last quarter’s data shows that trend has continued.

Q&A: Five C's help prevent, manage cataract surgery complications - Vimarsana News

Q&A: Five C's help prevent, manage cataract surgery complications

Cataract surgery is one of the most commonly performed procedures worldwide. Technological advances for preoperative assessment, IOL power calculation and surgical precision have increased safety and predictability, and the market offers a wide range of IOL options to satisfy patients’ needs. Nevertheless, unforeseen complications may occur, and some patients may be dissatisfied with their

Source: healio.com
Sizing Up Sight Sciences (NASDAQ:SGHT) - Vimarsana News

Sizing Up Sight Sciences (NASDAQ:SGHT)

Sight Sciences is seeing rapid revenue growth and over half of its market cap is net cash. Why am I still not enthusiastic about SGHT stock? Find out.

Analyzing Sight Sciences (SGHT) & Its Peers - Vimarsana News

Analyzing Sight Sciences (SGHT) & Its Peers

Sight Sciences (NASDAQ:SGHT – Get Rating) is one of 216 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare Sight Sciences to similar companies based on the strength of its earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and risk. Valuation and […]